Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
QTRX [NASD]
Quanterix Corporation
Healthcare | Medical Devices | USA
statements
Index- P/E- EPS (ttm)-1.17 Insider Own7.20% Shs Outstand30.14M Perf Week-1.60%
Market Cap2.66B Forward P/E- EPS next Y-1.09 Insider Trans-5.56% Shs Float26.49M Perf Month19.09%
Income-32.70M PEG- EPS next Q-0.33 Inst Own75.80% Short Float1.88% Perf Quarter77.08%
Sales76.20M P/S34.89 EPS this Y-13.40% Inst Trans-1.04% Short Ratio1.22 Perf Half Y118.54%
Book/sh6.94 P/B11.11 EPS next Y5.20% ROA-17.00% Target Price72.00 Perf Year226.14%
Cash/sh- P/C- EPS next 5Y- ROE-23.00% 52W Range10.90 - 92.57 Perf YTD65.81%
Dividend- P/FCF- EPS past 5Y- ROI-30.40% 52W High-23.38% Beta-
Dividend %- Quick Ratio7.20 Sales past 5Y- Gross Margin52.50% 52W Low551.03% ATR7.03
Employees248 Current Ratio7.70 Sales Q/Q110.70% Oper. Margin-43.60% RSI (14)44.99 Volatility8.14% 8.84%
OptionableYes Debt/Eq0.04 EPS Q/Q118.90% Profit Margin-42.90% Rel Volume1.54 Prev Close77.10
ShortableYes LT Debt/Eq0.01 EarningsMar 02 AMC Payout- Avg Volume405.90K Price70.93
Recom- SMA20-11.63% SMA505.99% SMA20065.31% Volume269,124 Change-8.00%
Mar-02-21 05:25PM  
Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates
Zacks -6.73%
04:03PM  
Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2020
Business Wire
Mar-01-21 10:05AM  
Preview: Quanterix's Earnings
Benzinga +9.12%
Feb-25-21 06:05PM  
Quanterix Kevin Hrusovsky to Present at the Cowen 41st Annual Health Care Conference on March 3 and Appear on the Feb. 26 Episode of the Health Care Rounds Podcast
Business Wire -5.62%
Feb-23-21 11:19AM  
Quanterix Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021
Business Wire
Feb-18-21 11:59AM  
Quanterix to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Business Wire
Feb-12-21 02:08PM  
Quanterix Announces Simoa® Joint Laboratory with WuXi AppTec
Business Wire +7.20%
Feb-09-21 08:41AM  
Did Business Growth Power Quanterix's (NASDAQ:QTRX) Share Price Gain of 287%?
Simply Wall St.
Feb-08-21 03:12PM  
Quanterix Announces Closing of Public Offering Including Exercise of Underwriters Option to Purchase Additional Shares
Business Wire
Feb-04-21 07:00AM  
Quanterix Prices Public Offering of Common Stock
Business Wire +9.67%
Feb-03-21 04:25PM  
Quanterix Announces Proposed Public Offering of $200.0 Million of its Common Stock
Business Wire
Jan-22-21 03:39PM  
Quanterix to Participate in PMWC 2021 COVID-19 Conference
Business Wire
Jan-13-21 08:30AM  
Quanterix Provides Operational and Preliminary Financial Highlights
Business Wire +13.81%
Jan-12-21 03:27AM  
Quanterixs Covid-19 Antigen Test Cleared For Emergency Use In US; Shares Pop 10%
SmarterAnalyst +12.75%
Jan-11-21 06:03PM  
Quanterix stock jumps nearly 10% after company gets EUA for COVID-19 test
MarketWatch +8.43%
04:30PM  
Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test
Business Wire
Jan-06-21 04:06PM  
Quanterix Corporation to Present At 39th Annual J.P. Morgan Healthcare Conference
Business Wire +5.19%
Dec-28-20 06:46PM  
Quanterix Receives FDA Emergency Use Authorization for Semi-Quantitative Antibody Test
Business Wire
Dec-10-20 12:02PM  
Is QTRX A Good Stock To Buy Now?
Insider Monkey +6.10%
Dec-09-20 09:00AM  
Quanterix to Participate in Contagion Conference
Business Wire
Nov-18-20 04:28PM  
Quanterix Appoints William Geist as Chief Operating Officer
Business Wire
Nov-13-20 12:36PM  
Quanterix to Participate in the Canaccord Medical Technologies and Diagnostics Forum
Business Wire
Nov-09-20 07:29AM  
Quanterix Corporation Beat Analyst Profit Forecasts, And Analysts Have New Estimates
Simply Wall St. -13.76%
Nov-05-20 04:16PM  
Quanterix Corporation Releases Operating Results for Third Quarter 2020
Business Wire
Oct-30-20 05:32PM  
908 Devices Names Kevin Hrusovsky, 30-year Biotechnology Veteran and Founder of Powering Precision Health, as Chairman of its Board of Directors
PR Newswire
Oct-29-20 02:40PM  
Quanterix Corporation to Release Third Quarter 2020 Financial Results on November 5, 2020
Business Wire
Oct-28-20 11:37AM  
Kevin Hrusovsky to Speak at Precision Medicine Leaders Summits Precision Oncology Conference
Business Wire
Oct-07-20 04:27PM  
Elanco Animal Health, 3D Systems: 5 Stock Gainers for Wednesday
TheStreet.com +17.56%
Oct-06-20 03:32PM  
Quanterix Receives National Institutes of Health RADx Contract to Advance Antigen Test for SARS-CoV-2 (COVID-19)
Business Wire
Oct-05-20 04:01PM  
Quanterix Enters into a License Agreement that Grants Abbott Access to Portfolio of Bead-Based Technology Patents for Use in In Vitro Diagnostics
Business Wire
Sep-10-20 09:00AM  
Quanterix Simoa Technology Supports 42 Scientific Presentations at MSVirtual2020
Business Wire
Aug-25-20 12:28PM  
What Is The Ownership Structure Like For Quanterix Corporation (NASDAQ:QTRX)?
Simply Wall St.
Aug-11-20 04:34PM  
Quanterix Announces Closing of Public Offering Including Exercise in Full of Underwriters Option to Purchase Additional Shares
Business Wire
09:00AM  
Quanterix to Participate in the Canaccord Genuity 40th Annual Growth Conference
Business Wire
Aug-06-20 10:12PM  
Quanterix Prices Public Offering of Common Stock
Business Wire
04:11PM  
Quanterix Announces Proposed Public Offering of Common Stock
Business Wire
Aug-04-20 04:29PM  
Quanterix Corporation Releases Operating Results for Second Quarter 2020
Business Wire
Aug-03-20 09:08AM  
Quanterix Corporation to Release Second Quarter 2020 Financial Results on August 4, 2020
Business Wire
Jul-29-20 09:30AM  
Quanterix sNfL Assay and Simoa Technology First to Measure Neuronal Injury in COVID-19 Patients Blood
Business Wire +12.54%
Jul-27-20 07:00AM  
Quanterix to Participate in Alzheimers Association International Conference (AAIC) 2020
Business Wire
Jul-20-20 10:41AM  
Quanterix Simoa Technology Powers New Insights into COVID-19 Immune Response and Reveals Indicators of Disease Severity
Business Wire
Jul-05-20 10:02PM  
Is Quanterix Corporation (QTRX) A Good Stock To Buy?
Insider Monkey
Jun-26-20 09:37AM  
Quanterix Corporation CEO to Present at MassBio: Possible Talk Series
Business Wire
Jun-11-20 04:10PM  
Quanterix to Host Virtual Annual Meeting of Stockholders
Business Wire -6.24%
May-29-20 12:37PM  
Quanterix Expands Menu of Ultra-Sensitive Neurology Assays with Simoa® P-Tau181 V2 Kit for Improved Detection and Study of Alzheimers Disease
Business Wire
May-13-20 09:45AM  
Quanterix Simoa Technology Sets New Standard in Protein Detection
Business Wire
May-11-20 09:14AM  
Quanterix Corporation (NASDAQ:QTRX) Just Reported And Analysts Have Been Cutting Their Estimates
Simply Wall St.
08:26AM  
Researchers Develop Breakthrough COVID-19 Antibody Test with 1,000-Fold Sensitivity Improvement Using Quanterix Simoa Technology
Business Wire
May-06-20 10:02AM  
Quanterix Corporation (QTRX) Q1 2020 Earnings Call Transcript
Motley Fool +7.66%
May-05-20 04:05PM  
Quanterix Corporation Releases Operating Results for First Quarter 2020
Business Wire
May-01-20 11:00AM  
Quanterix CEO and Powering Precision Health Founder Kevin Hrusovsky to Appear on Passionate Pioneers Podcast
Business Wire
Apr-28-20 02:45PM  
Quanterix to Release First Quarter 2020 Financial Results and Host Conference Call on May 5, 2020
Business Wire
Apr-24-20 06:04PM  
Quanterix Announces Simoa® Success Grant Program to Accelerate Promising Infectious Disease & Immunology Research
Business Wire +7.09%
Apr-14-20 10:05AM  
How Quanterix (QTRX) Stock Stands Out in a Strong Industry
Zacks +8.21%
Apr-10-20 04:00PM  
Quanterix Ultra-Sensitive Simoa Technology Demonstrates Promise for COVID-19 Acute Care, Immune Response Monitoring and Treatment
Business Wire
Apr-09-20 01:15PM  
Quanterix Corporation to Participate in the 19th Annual Needham Virtual Healthcare Conference
Business Wire -8.11%
Mar-27-20 09:45AM  
Quanterix Statement on COVID-19 Preparedness, Resiliency Efforts and Business Continuity
Business Wire
Mar-11-20 08:13AM  
Quanterix Corporation Annual Results: Here's What Analysts Are Forecasting For Next Year
Simply Wall St. -6.52%
Mar-09-20 04:05PM  
Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2019
Business Wire -9.30%
Feb-21-20 04:32PM  
Quanterix Corporation to Release Fourth Quarter 2019 Financial Results on March 9, 2020 and Present at Multiple Upcoming Healthcare Conferences
Business Wire
Feb-11-20 11:44AM  
Quanterix (NASDAQ:QTRX) Is Using Debt Safely
Simply Wall St.
Jan-31-20 10:04AM  
Quanterix Simoa Technology Advances the Field Toward a Sports-Related Concussion Blood Test
Business Wire
Jan-10-20 02:03PM  
Quanterix Corporation to Present at 38th Annual J.P. Morgan Healthcare Conference
Business Wire
Dec-19-19 04:23PM  
Hedge Funds Have Never Been This Bullish On Quanterix Corporation (QTRX)
Insider Monkey
Dec-11-19 10:27AM  
Does The Quanterix Corporation (NASDAQ:QTRX) Share Price Fall With The Market?
Simply Wall St.
Nov-06-19 04:01PM  
Quanterix Corporation Releases Operating Results for Third Quarter 2019
Business Wire -5.07%
Nov-04-19 04:00PM  
Siemens Healthineers Enters into License and Supply Arrangement with Quanterix for Access to Neurofilament Light (Nf-L) Antibodies to Develop Nf-L Assays
Business Wire
Nov-01-19 09:41AM  
Hedge Funds Have Never Been More Bullish On Quanterix Corporation (QTRX)
Insider Monkey
Oct-25-19 09:13AM  
Quanterix Simoa Technology Unlocks Low-Level Markers Critical to Rapid Triage Test in Study for Active Pulmonary Tuberculosis
Business Wire
Oct-22-19 04:30PM  
Quanterix to Release Third Quarter 2019 Financial Results and Host Conference Call on November 6, 2019
Business Wire
Oct-18-19 11:13AM  
3 Medical Product Stocks Likely to Beat This Earnings Season
Zacks
Oct-03-19 09:00AM  
Quanterix Announces Recipients of Annual Accelerator Grant Program
Business Wire +11.06%
Oct-01-19 09:46AM  
Need To Know: Quanterix Corporation (NASDAQ:QTRX) Insiders Have Been Selling Shares
Simply Wall St.
Sep-26-19 07:00AM  
Sherlock Bio gets DoD grant to bring CRISPR to the battlefield
American City Business Journals
Sep-24-19 01:14PM  
Powering Precision Health Announces 2019 Summit
Business Wire -5.86%
Sep-16-19 06:21PM  
Quanterix Serum Nf-L Assay Powers Key Trial and Study Results Presented at ECTRIMS 2019
Business Wire
Sep-11-19 08:00AM  
Quanterix Simoa Technology Powers Multiple Sclerosis Research with More Than 50 Presentations at ECTRIMS 2019
Business Wire +7.48%
Aug-13-19 04:21PM  
Quanterix Announces Closing of Public Offering Including Exercise of Underwriters Option to Purchase Additional Shares
Business Wire
Aug-09-19 07:45AM  
Quanterix Prices Public Offering of Common Stock
Business Wire
Aug-07-19 04:23PM  
Quanterix Announces Proposed Public Offering of Common Stock
Business Wire
08:25AM  
Quanterix Corporation (QTRX) Q2 2019 Earnings Call Transcript
Motley Fool
Aug-06-19 08:30AM  
Quanterix Corporation Releases Operating Results for Second Quarter 2019
Business Wire
Jul-31-19 09:00AM  
Quanterix to Present at the Canaccord Genuity 39th Annual Growth Conference
Business Wire
Jul-30-19 10:30AM  
Quanterix to Release Second Quarter 2019 Financial Results and Host Conference Call on Tuesday, August 6, 2019
Business Wire
Jul-26-19 11:16AM  
Sarah Hlavinka Elected to Quanterix Board of Directors
Business Wire
Jul-11-19 01:30PM  
Quanterix to Convene Leading Industry Researchers at Alzheimers Association International Conference 2019 Following Closing of UmanDiagnostics Acquisition
Business Wire
Jun-28-19 12:15PM  
Quanterix Announces Kevin Hrusovsky, Chairman and Chief Executive Officer, and Founder of Powering Precision Health, as EY Entrepreneur Of The Year® 2019 Award Winner in New England
Business Wire
Jun-27-19 10:43AM  
Mass. diagnostics firms sign M&A deals worth $500M
American City Business Journals +8.95%
Jun-26-19 04:00PM  
Quanterix Announces Agreement to Acquire UmanDiagnostics, Worlds Leading Neurofilament Light (Nf-L) Antibody Supplier
Business Wire
Jun-06-19 07:03AM  
Did Quanterix's (NASDAQ:QTRX) Share Price Deserve to Gain 66%?
Simply Wall St.
Jun-04-19 04:00PM  
Quanterix Raises $49.7 Million and Announces Introduction of Latest Model Simoa HD-X Analyzer at BIO 2019 International Convention
Business Wire
May-29-19 04:00PM  
Quanterix Expands Headquarters to New, State-of-the-Art Facility in Billerica, Mass. as Demand Continues to Grow for its Disruptive Simoa Platforms
Business Wire
May-16-19 10:30AM  
Quanterix Announces $50,000 in Grants to Support Promising Oncology Research
Business Wire
May-11-19 01:27PM  
Heres What Hedge Funds Think About Quanterix Corporation (QTRX)
Insider Monkey
May-10-19 11:23AM  
Quanterix Corporation (QTRX) Q1 2019 Earnings Call Transcript
Motley Fool
May-09-19 04:00PM  
Quanterix Corporation Releases Operating Results for First Quarter 2019
Business Wire
May-06-19 11:30AM  
Quanterix Simoa Technology Powers More Than 85 Percent of Neurofilament Light Biomarker Research to be Unveiled at American Academy of Neurology Annual Meeting
Business Wire
May-02-19 04:00PM  
Quanterix to Release First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019
Business Wire
Apr-01-19 07:14AM  
Will Quanterix Corporation's (NASDAQ:QTRX) Earnings Grow In The Next Couple Of Years?
Simply Wall St. -9.41%
Mar-28-19 04:00PM  
Quanterix Appoints Amol Chaubal as Chief Financial Officer
Business Wire
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also develops SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sell its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HRUSOVSKY E KEVINChairman, President & CEOFeb 19Sale90.343,493315,5621,002,443Feb 22 04:34 PM
Roskey Mark T.SVP, Commercial & AcceleratorFeb 19Sale90.3367060,52324,435Feb 23 04:43 PM
Chaubal AmolChief Financial OfficerFeb 19Sale90.3373366,21230,423Feb 23 04:45 PM
Mattoon DawnSr. VP, Research ProductsFeb 19Sale90.3387178,68033,642Feb 23 04:36 PM
Fry John JGeneral Counsel & SecretaryFeb 19Sale90.3387178,68034,530Feb 23 04:39 PM
HRUSOVSKY E KEVINChairman, President & CEOFeb 18Sale83.655,000418,2291,005,936Feb 22 04:34 PM
Duffy David C.SVP R&D and CTOFeb 11Sale79.621,667132,72739,952Feb 12 04:00 PM
HRUSOVSKY E KEVINChairman, President & CEOFeb 09Sale78.185,000390,8871,010,936Feb 10 04:11 PM
Roskey Mark T.SVP, Commercial & AcceleratorFeb 01Sale68.261057,16721,732Feb 02 07:56 PM
Fry John JGeneral Counsel & SecretaryFeb 01Sale68.2616311,12631,722Feb 02 08:02 PM
Chaubal AmolChief Financial OfficerFeb 01Sale68.261339,07825,367Feb 02 08:04 PM
HRUSOVSKY E KEVINChairman, President & CEOFeb 01Sale66.778,249550,788997,539Feb 02 08:12 PM
Mattoon DawnSr. VP, Research ProductsFeb 01Sale68.2618212,42330,834Feb 02 09:13 PM
HRUSOVSKY E KEVINChairman, President & CEOJan 25Sale77.815,000389,0561,005,788Jan 25 04:01 PM
Duffy David C.SVP R&D and CTOJan 22Sale79.291,667132,17639,473Jan 22 06:47 PM
HRUSOVSKY E KEVINChairman, President & CEOJan 19Sale74.535,000372,6461,010,788Jan 21 07:55 PM
DEKKERS MARIJN EDirectorJan 11Option Exercise11.1044,962498,97854,042Jan 13 05:01 PM
DEKKERS MARIJN EDirectorJan 11Sale48.6544,9622,187,5149,080Jan 13 05:01 PM
Mattoon DawnSr. VP, Research ProductsJan 05Sale44.131707,50231,016Jan 06 04:21 PM
Roskey Mark T.SVP, Commercial & AcceleratorJan 05Sale44.13984,32521,837Jan 06 04:21 PM
Fry John JGeneral Counsel & SecretaryJan 05Sale44.131536,75231,885Jan 06 04:21 PM
HRUSOVSKY E KEVINChairman, President & CEOJan 05Sale44.133,510154,9021,015,788Jan 06 04:21 PM
Chaubal AmolChief Financial OfficerJan 05Sale44.131245,47225,500Jan 06 04:23 PM
Duffy David C.SVP R&D and CTODec 18Option Exercise2.281,6303,71642,807Dec 21 05:03 PM
Duffy David C.SVP R&D and CTODec 18Sale43.821,66773,04841,140Dec 21 05:03 PM
HRUSOVSKY E KEVINChairman, President & CEODec 08Sale46.982,00093,9601,019,298Dec 10 05:48 PM
Roskey Mark T.SVP, Commercial & AcceleratorDec 01Sale43.75913,98121,935Dec 03 04:41 PM
Mattoon DawnSr. VP, Research ProductsDec 01Sale43.751586,91231,186Dec 03 04:40 PM
Chaubal AmolChief Financial OfficerDec 01Sale43.751155,03125,624Dec 03 04:40 PM
Fry John JGeneral Counsel & SecretaryDec 01Sale43.751416,16832,038Dec 03 04:40 PM
HRUSOVSKY E KEVINChairman, President & CEODec 01Sale43.753,236141,5691,021,298Dec 03 04:40 PM
HRUSOVSKY E KEVINChairman, President & CEONov 19Sale44.252,00088,5001,024,534Nov 20 04:19 PM
HRUSOVSKY E KEVINChairman, President & CEONov 12Sale49.392,00098,7801,026,534Nov 16 04:51 PM
Duffy David C.SVP R&D and CTONov 12Sale49.391,66782,33341,177Nov 16 04:51 PM
Madaus Martin DDirectorNov 05Option Exercise2.281,3723,12813,088Nov 06 04:01 PM
Madaus Martin DDirectorNov 05Sale42.451,37258,24111,716Nov 06 04:01 PM
Madaus Martin DDirectorNov 04Option Exercise2.281,6003,64813,316Nov 06 04:01 PM
Madaus Martin DDirectorNov 04Sale39.401,60063,04011,716Nov 06 04:01 PM
Chaubal AmolChief Financial OfficerNov 02Sale36.971164,28825,261Nov 03 04:04 PM
HRUSOVSKY E KEVINChairman, President & CEONov 02Sale36.973,264120,6661,028,534Nov 03 04:05 PM
Fry John JGeneral Counsel & SecretaryNov 02Sale36.971425,25031,085Nov 03 04:04 PM
Mattoon DawnSr. VP, Research ProductsNov 02Sale36.971595,87831,344Nov 03 04:09 PM
Roskey Mark T.SVP, Commercial & AcceleratorNov 02Sale36.97913,36421,188Nov 03 04:13 PM
HRUSOVSKY E KEVINChairman, President & CEOOct 29Sale38.302,00076,6001,031,798Nov 03 04:05 PM
Madaus Martin DDirectorOct 20Option Exercise2.281,6003,64813,316Oct 20 04:24 PM
Madaus Martin DDirectorOct 20Sale42.571,60068,11211,716Oct 20 04:24 PM
Madaus Martin DDirectorOct 19Option Exercise2.281,6003,64813,316Oct 20 04:24 PM
Madaus Martin DDirectorOct 19Sale44.591,60071,34411,716Oct 20 04:24 PM
Duffy David C.SVP R&D and CTOOct 16Sale43.041,66771,74842,844Oct 20 04:15 PM
HRUSOVSKY E KEVINChairman, President & CEOOct 13Sale44.492,00088,9801,033,798Oct 15 05:36 PM
Madaus Martin DDirectorOct 07Option Exercise2.281,6003,64813,316Oct 08 05:43 PM
Madaus Martin DDirectorOct 07Sale37.171,60059,47211,716Oct 08 05:43 PM
Madaus Martin DDirectorOct 06Option Exercise2.281,6003,64813,316Oct 08 05:43 PM
Madaus Martin DDirectorOct 06Sale36.471,60058,35711,716Oct 08 05:43 PM
HRUSOVSKY E KEVINChairman, President & CEOOct 05Sale33.902,00067,8001,035,798Oct 05 05:29 PM
Roskey Mark T.SVP, Commercial & AcceleratorOct 01Sale34.12923,13921,279Oct 02 04:00 PM
Chaubal AmolChief Financial OfficerOct 01Sale34.121163,95825,377Oct 02 04:00 PM
Mattoon DawnSr. VP, Research ProductsOct 01Sale34.121595,42531,503Oct 02 04:00 PM
HRUSOVSKY E KEVINChairman, President & CEOOct 01Sale34.123,286112,1261,037,798Oct 02 04:00 PM
Fry John JGeneral Counsel & SecretaryOct 01Sale34.121434,88031,227Oct 02 04:00 PM
Madaus Martin DDirectorSep 29Option Exercise1.961,6003,13812,654Sep 30 04:10 PM
Madaus Martin DDirectorSep 29Sale32.521,60052,02511,196Sep 30 04:10 PM
Madaus Martin DDirectorSep 28Option Exercise1.931,6003,08812,796Sep 30 04:10 PM
Madaus Martin DDirectorSep 28Sale33.091,60052,94411,196Sep 30 04:10 PM
HRUSOVSKY E KEVINChairman, President & CEOSep 24Sale32.262,00064,5201,041,084Sep 29 04:53 PM
Madaus Martin DDirectorSep 17Option Exercise1.931,6003,08812,796Sep 17 05:49 PM
Duffy David C.SVP R&D and CTOSep 17Sale32.431,66754,06144,511Sep 17 05:47 PM
Madaus Martin DDirectorSep 17Sale32.431,60051,88811,196Sep 17 05:49 PM
Madaus Martin DDirectorSep 16Option Exercise1.931,6003,08812,796Sep 17 05:49 PM
Madaus Martin DDirectorSep 16Sale33.161,60053,05611,196Sep 17 05:49 PM
HRUSOVSKY E KEVINChairman, President & CEOSep 15Sale33.153,500116,0371,043,084Sep 16 04:08 PM
Madaus Martin DDirectorSep 02Option Exercise1.931,6003,08812,796Sep 03 07:44 PM
Madaus Martin DDirectorSep 02Sale35.081,60056,12811,196Sep 03 07:44 PM
Madaus Martin DDirectorSep 01Option Exercise1.931,6003,08812,796Sep 03 07:44 PM
Madaus Martin DDirectorSep 01Sale35.371,60056,59211,196Sep 03 07:44 PM
HRUSOVSKY E KEVINChairman, President & CEOSep 01Sale34.913,390118,3491,046,584Sep 03 07:48 PM
Mattoon DawnSr. VP, Research ProductsSep 01Sale34.911655,76031,662Sep 03 07:50 PM
Fry John JGeneral Counsel & SecretarySep 01Sale34.911485,16731,370Sep 03 07:52 PM
Chaubal AmolChief Financial OfficerSep 01Sale34.911204,18925,493Sep 03 07:54 PM
Roskey Mark T.SVP, Commercial & AcceleratorSep 01Sale34.91953,31721,371Sep 03 07:56 PM
HRUSOVSKY E KEVINChairman, President & CEOAug 25Sale35.283,500123,4681,049,974Aug 26 05:09 PM
Madaus Martin DDirectorAug 19Option Exercise1.931,6003,08812,796Aug 20 04:32 PM
Duffy David C.SVP R&D and CTOAug 19Sale34.921,68058,66646,178Aug 20 04:32 PM
Madaus Martin DDirectorAug 19Sale34.921,60055,87211,196Aug 20 04:32 PM
Madaus Martin DDirectorAug 18Option Exercise1.931,6003,08812,796Aug 20 04:32 PM
Madaus Martin DDirectorAug 18Sale34.521,60055,23211,196Aug 20 04:32 PM
HRUSOVSKY E KEVINChairman, President & CEOAug 14Sale36.723,500128,5331,053,474Aug 14 05:40 PM
DEKKERS MARIJN EDirectorAug 07Sale32.4927,619897,3410Aug 11 04:52 PM
Madaus Martin DDirectorAug 05Option Exercise1.933,2006,17614,396Aug 05 05:49 PM
Madaus Martin DDirectorAug 05Sale32.893,200105,24811,196Aug 05 05:49 PM
HRUSOVSKY E KEVINChairman, President & CEOAug 04Sale32.114,000128,4371,056,974Aug 05 05:14 PM
Chaubal AmolChief Financial OfficerAug 03Sale32.261143,67725,613Aug 05 05:21 PM
HRUSOVSKY E KEVINChairman, President & CEOAug 03Sale32.263,230104,1881,060,974Aug 05 05:14 PM
Fry John JGeneral Counsel & SecretaryAug 03Sale32.251414,54831,518Aug 05 05:10 PM
Roskey Mark T.SVP, Commercial & AcceleratorAug 03Sale32.25902,90321,466Aug 05 05:51 PM
Mattoon DawnSr. VP, Research ProductsAug 03Sale32.261565,03231,827Aug 05 05:53 PM
Madaus Martin DDirectorJul 21Option Exercise1.931,6003,08812,796Jul 22 07:13 PM
Madaus Martin DDirectorJul 21Sale31.451,60050,32011,196Jul 22 07:13 PM
HRUSOVSKY E KEVINChairman, President & CEOJul 21Sale31.872,63684,0161,064,204Jul 23 08:38 PM
Madaus Martin DDirectorJul 20Option Exercise1.931,6003,08812,796Jul 22 07:13 PM
open in yahoo | open in reuters | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.